Heterocyclic Fatty Acids

CMPF can be found in trace constituent of urine and blood. CMPF is a biomarker of type 2 diabetes. CMPF can act on the β cell and induces impaired mitochondrial function. CMPF decreases glucose-induced ATP accumulation, and induces oxidative stress. CMPF reverses hepatic lipid accumulation and improves insulin sensitivity in obese mice.

Furan fatty acid F6 (3,4-dimethyl-5-pentyl-2-furanundecanoic acid) is an ester product.

3,4-Dimethyl-5-pentyl-2-furannonanoic acid is a furan fatty acid with a pentyl side chain. It is produced from Linoleic acid (HY-N0729). 3,4-Dimethyl-5-pentyl-2-furannonanoic acid counteracts the negative effects associated with intracellular oxidative stress.

3,4-Dimethyl-5-pentyl-2-furanpentadecanoic acid is a serum metabolic marker. Pre-treatment with lauric acid (HY-Y0366) can specifically increase the level of 3,4-Dimethyl-5-pentyl-2-furanpentadecanoic acid in the serum.

8-(5-Hexylfuran-2-yl)octanoic acid (9,12-Epoxy-9,11-octadecadienoic acid) is an ester product.

10,13-Epoxy-10,12-octadecadienoic acid (5-Pentyl-2-furannonanoic acid; 10,13-Epoxy-octadeca-10,12-dienoic acid) is an ester product.

10,13-Epoxy-11-methyl-octadecadienoic acid is an ester product.

12,15-epoxy-13-methyl-12,14-Eicosadienoic acid is a furan fatty acid originally isolated from northern pike (E. lucius).1 Levels of 12,15-epoxy-13-methyl-12,14-eicosadienoic acid are increased in the liver of starving cod.